In today’s session Colgate-Palmolive Company (CL) registered an unusually high (705) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the January, 2017 call, expecting serious CL increase. With 705 contracts traded and 78664 open interest for the Jan, 17 contract, it seems this is a quite bullish bet. The option with symbol: CL170120C00075000 closed last at: $0.38 or 35.6% down. About 920,815 shares traded hands. Colgate-Palmolive Company (NYSE:CL) has risen 0.94% since March 29, 2016 and is uptrending. It has underperformed by 2.54% the S&P500.
Analysts await Colgate-Palmolive Company (NYSE:CL) to report earnings on November, 4. They expect $0.73 earnings per share, up 1.39% or $0.01 from last year’s $0.72 per share. CL’s profit will be $654.41M for 24.51 P/E if the $0.73 EPS becomes a reality. After $0.70 actual earnings per share reported by Colgate-Palmolive Company for the previous quarter, Wall Street now forecasts 4.29% EPS growth.
Colgate-Palmolive Company (NYSE:CL) Ratings Coverage
Out of 16 analysts covering Colgate-Palmolive (NYSE:CL), 3 rate it a “Buy”, 0 “Sell”, while 13 “Hold”. This means 19% are positive. $88 is the highest target while $65 is the lowest. The $72.63 average target is 1.50% above today’s ($71.56) stock price. Colgate-Palmolive has been the topic of 29 analyst reports since July 21, 2015 according to StockzIntelligence Inc. The company was upgraded on Friday, September 4 by Zacks. The firm has “Overweight” rating given on Wednesday, January 6 by Atlantic Securities. Deutsche Bank maintained the stock with “Hold” rating in Monday, November 2 report. B. Riley & Co maintained Colgate-Palmolive Company (NYSE:CL) on Friday, October 28 with “Neutral” rating. Sterne Agee CRT downgraded the stock to “Neutral” rating in Friday, February 26 report. The rating was maintained by S&P Research with “Hold” on Monday, November 2. BNP Paribas upgraded the shares of CL in a report on Friday, January 15 to “Outperform” rating. As per Thursday, April 14, the company rating was maintained by Citigroup. UBS maintained the shares of CL in a report on Friday, April 29 with “Neutral” rating. On Wednesday, August 5 the stock rating was downgraded by Zacks to “Hold”.
According to Zacks Investment Research, “Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Household Surface Care, Fabric Care and Pet Nutrition. Colgate sells its products in countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Ajax, Axion, Soupline, Suavitel and Fab, as well as Hill’s Science Diet and Hill’s Prescription Diet pet foods. (Company Press Release)”
Insitutional Activity: The institutional sentiment decreased to 0.87 in Q2 2016. Its down 0.04, from 0.91 in 2016Q1. The ratio is negative, as 47 funds sold all Colgate-Palmolive Company shares owned while 440 reduced positions. 53 funds bought stakes while 371 increased positions. They now own 618.55 million shares or 5.94% less from 657.64 million shares in 2016Q1.
Aviva Public Limited Com owns 882,512 shares or 0.44% of their US portfolio. Hallmark Mngmt reported 800 shares or 0.01% of all its holdings. Aqr Capital Limited Liability Company last reported 1.29M shares in the company. Moreover, Tokio Marine Asset Mngmt Ltd has 1.72% invested in Colgate-Palmolive Company (NYSE:CL) for 227,666 shares. Analytic Llc has invested 0.01% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Stock Yards Financial Bank & reported 10,498 shares or 0.1% of all its holdings. The New Jersey-based Glovista Invests Ltd has invested 0.07% in Colgate-Palmolive Company (NYSE:CL). Regions Financial Corp last reported 0.18% of its portfolio in the stock. Aull Monroe Mngmt holds 42,046 shares or 1.77% of its portfolio. Parthenon Ltd Liability Corporation owns 34,618 shares or 0.64% of their US portfolio. Great Lakes Advisors Ltd Liability Corp holds 0.09% of its portfolio in Colgate-Palmolive Company (NYSE:CL) for 46,882 shares. Burns J W And Ny holds 4,894 shares or 0.11% of its portfolio. Blackrock Gru last reported 0.26% of its portfolio in the stock. The Massachusetts-based Penobscot Management has invested 0.25% in Colgate-Palmolive Company (NYSE:CL). Moreover, Lombard Odier Transatlantic Lp has 0.2% invested in Colgate-Palmolive Company (NYSE:CL) for 2,620 shares.
Insider Transactions: Since May 3, 2016, the stock had 0 buys, and 16 insider sales for $19.71 million net activity. $275,473 worth of Colgate-Palmolive Company (NYSE:CL) shares were sold by Verduin Patricia. Shares for $1.05M were sold by HUSTON JOHN J. 4,566 Colgate-Palmolive Company (NYSE:CL) shares with value of $328,085 were sold by HANCOCK ELLEN M. $1.13 million worth of Colgate-Palmolive Company (NYSE:CL) was sold by MOISON FRANCK J. $1.39 million worth of shares were sold by Dolan Victoria L on Tuesday, May 3. 8,803 shares were sold by SADOVE STEPHEN I, worth $653,927. KOGAN RICHARD J sold $597,254 worth of stock or 8,000 shares.
Colgate-Palmolive Company is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The company has a market cap of $64.15 billion. The Company’s divisions include Oral, Personal and Home Care, and Pet Nutrition. It has a 46.84 P/E ratio. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia.
CL Company Profile
Colgate-Palmolive Company (Colgate), incorporated on July 25, 1923, is a consumer products company, whose products are marketed in over 200 countries and territories throughout the world. The Firm operates in two product divisions: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through over five geographic divisions, which include North America, Latin America, Europe/South Pacific, Asia and Africa/Eurasia. The Company’s oral care products include Colgate Total; Colgate Sensitive Pro-Relief; Colgate Max Fresh; Colgate Maximum Cavity Protection with Sugar Acid Neutralizer; Colgate Optic White and Colgate Luminous White toothpastes, and Colgate Optic White, Colgate Total and Colgate Plax mouthwashes. Colgate’s Oral Care business also includes pharmaceutical products for dentists and other oral health professionals. The Firm sells its personal care products under the Palmolive, Protex and Softsoap brands. The Company, through its Hill’s Pet Nutrition segment (Hill’s), makes pet nutrition products for dogs and cats with products marketed in over 80 countries across the world.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.